{
    "root": "dc51d382-0b0a-44bc-9b6e-22c138ad9c60",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Sildenafil"
    },
    "value": "20241220",
    "ingredients": [
        {
            "name": "SILDENAFIL CITRATE",
            "code": "BW9B0ZE037"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        }
    ],
    "indications": "adults sildenafil tablets , usp indicated treatment pulmonary arterial hypertension ( pah ) ( world health organization [ ] group ) adults improve exercise ability delay worsening [ ( 14 ) ] . pediatric information approved viatris specialty llc 's , revatio ( sildenafil ) tablets . however , due viatris specialty llc 's marketing exclusivity rights , product labeled information .",
    "contraindications": "adults : 20 mg three times day . ( 2.1 )",
    "warningsAndPrecautions": "sildenafil tablets , usp supplied white , film-coated , circular , biconvex tablets containing sildenafil citrate equivalent nominally indicated amount sildenafil follows : sildenafil tablets , usp package configuration strength ndc debossing tablet bottle 90 tablets child-resistant closure 20 mg 27241-124-03 'sc ' one side '20 ' side recommended storage sildenafil tablets : store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] .",
    "adverseReactions": "sildenafil tablets contraindicated patients : concomitant organic nitrates form , either regularly intermittently , greater risk hypotension [ ( 5.1 ) ] . concomitant riociguat , guanylate cyclase stimulator . phosphodiesterase-5 ( pde-5 ) inhibitors , including sildenafil , may potentiate hypotensive effects riociguat . known hypersensitivity sildenafil component tablet . hypersensitivity , including anaphylactic reaction , anaphylactic shock anaphylactoid reaction , reported association sildenafil .",
    "indications_original": "Adults\n                  \n                  Sildenafil tablets, USP are indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I)\u00a0in adults to improve exercise ability and delay clinical worsening\u00a0[see Clinical Studies (14)].\n                  \n                  \n                     Pediatric use information is approved for Viatris Specialty LLC's, REVATIO (sildenafil) tablets. However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information.",
    "contraindications_original": "Adults: 20 mg three times a day. ( 2.1 )",
    "warningsAndPrecautions_original": "Sildenafil tablets, USP are supplied as white, film-coated, circular, biconvex tablets containing sildenafil citrate equivalent to the nominally indicated amount of sildenafil as follows:\n                  \n                     \n                        \n                        \n                        \n                        \n                     \n                     \n                        \n                           \u00a0Sildenafil Tablets, USP\u00a0\n                        \n                        \n                           \u00a0Package Configuration\u00a0\n                           \u00a0Strength\u00a0\n                           \u00a0NDC\u00a0\n                           \u00a0Debossing on Tablet\u00a0\n                        \n                        \n                           \u00a0Bottle of 90 Tablets\u00a0with child-resistant closure\u00a0\u00a0\u00a0\n                           \u00a020 mg\u00a0\n                           \u00a027241-124-03\u00a0\n                           \u00a0'SC' on one side and '20' on other side\u00a0\n                        \n                     \n                  \n                  Recommended Storage for Sildenafil Tablets: Store at 20\u00b0C to 25\u00b0C (68\u00b0F to 77\u00b0F); excursions permitted to 15\u00b0C to 30\u00b0C (59\u00b0F to 86\u00b0F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Sildenafil tablets are contraindicated in patients with: \n                  \n                     Concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see Warnings and Precautions (5.1)].\n                     \n                     Concomitant use of riociguat, a guanylate cyclase stimulator. Phosphodiesterase-5 (PDE-5)\u00a0inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat.\n                     Known hypersensitivity to sildenafil or any component of the tablet. Hypersensitivity, including anaphylactic reaction, anaphylactic shock and anaphylactoid reaction, has been reported in association with the use of sildenafil."
}